medroxyprogesterone acetate has been researched along with Angiogenesis, Pathologic in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (25.00) | 18.7374 |
| 1990's | 7 (35.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, MR; Christov, K; Ivancic, D; Khan, SA; Lee, O | 1 |
| Benakanakere, I; Besch-Williford, C; Ellersieck, MR; Hyder, SM | 1 |
| Benakanakere, I; Besch-Williford, C; Ellersieck, MR; Hyder, SM; López Pérez, FR; Mafuvadze, B | 1 |
| Chai, CY; Lee, KT; Wang, SN; Yang, SF; Yeh, YT | 1 |
| Benakanakere, I; Besch-Williford, C; Brandt, S; Ellersieck, MR; Hyder, SM; Molinolo, A; Schnell, J | 1 |
| Besch-Williford, C; Brekken, RA; Hyder, SM; Liang, Y | 1 |
| Arffa, R; Cintron, C; Kenyon, KR; Kublin, CL; Miller, D; Phillips, K; Rose, J | 1 |
| Nishizawa, Y; Petrow, V; Terada, N; Yamamoto, T | 1 |
| Blei, F; Mignatti, P; Rifkin, DB; Wilson, EL | 1 |
| Fujimoto, J; Hori, M; Ichigo, S; Tamaya, T | 1 |
| Hyder, SM; Murthy, L; Stancel, GM | 1 |
| Toi, M | 1 |
| Abulafia, O; Adcock, JT; Sherer, DM; Triest, WE | 1 |
| Hibino, S; Kohno, T; Murata, N; Oikawa, T; Shimamura, M; Sugino, E; Tsuboi, H; Uchida, M; Yamaji, T | 1 |
| Kunisue, H; Kurebayashi, J; Kurosumi, M; Otsuki, T; Sonoo, H; Yamamoto, S | 1 |
| Jikihara, H; Matsumoto, K; Nishikawa, Y; Tanizawa, O; Terada, N; Terakawa, N; Yamamoto, R | 1 |
| Ashino-Fuse, H; Hiragun, A; Iwaguchi, T; Oikawa, T; Tominaga, T; Yoshida, Y | 1 |
| Fujimoto, J; Fujita, H; Hosoda, S; Okada, H | 2 |
| Ashino-Fuse, H; Iwaguchi, T; Oikawa, T; Shimamura, M; Takano, Y | 1 |
1 review(s) available for medroxyprogesterone acetate and Angiogenesis, Pathologic
| Article | Year |
|---|---|
[Antiangiogenic therapy].
Topics: Angiostatins; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Collagen; Endostatins; Endothelial Growth Factors; Humans; Lymphokines; Medroxyprogesterone Acetate; Mice; Neoplasms; Neovascularization, Pathologic; Peptide Fragments; Plasminogen; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
19 other study(ies) available for medroxyprogesterone acetate and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antigens, CD34; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Hormone Antagonists; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Methylnitrosourea; Mice; Mifepristone; Neovascularization, Pathologic; Norpregnadienes; Progesterone; Progestins; Rats; Receptors, Estrogen; Receptors, Progesterone; Time Factors | 2016 |
Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carcinogens; Drug Resistance, Neoplasm; Female; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Mutation; Neovascularization, Pathologic; Osteonectin; Pilot Projects; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A | 2009 |
Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apigenin; Dose-Response Relationship, Drug; Female; Immunohistochemistry; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Neovascularization, Pathologic; Placebos; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Potential role of leptin expression in hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Carcinoma, Hepatocellular; Disease Progression; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Leptin; Liver Neoplasms; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Proteins; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Prognosis; Survival Analysis; Treatment Outcome | 2006 |
Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Implants; Immunohistochemistry; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mifepristone; Neovascularization, Pathologic; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Time Factors; Vascular Endothelial Growth Factors | 2006 |
Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.
Topics: Angiogenesis Inhibitors; Animals; Aza Compounds; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Growth Processes; Disease Progression; Female; Humans; Medroxyprogesterone Acetate; Mice; Mifepristone; Neoplasms, Hormone-Dependent; Neovascularization, Pathologic; Progesterone; Progesterone Congeners; Progestins; Receptors, Estrogen; Receptors, Progesterone; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2007 |
Effects of prednisolone and medroxyprogesterone on corneal wound healing, ulceration, and neovascularization.
Topics: Animals; Collagen; Cornea; Corneal Injuries; Corneal Ulcer; Medroxyprogesterone; Medroxyprogesterone Acetate; Neovascularization, Pathologic; Prednisolone; Rabbits; Wound Healing | 1983 |
Angiostatic activities of medroxyprogesterone acetate and its analogues.
Topics: Animals; Cattle; Cell Division; Cells, Cultured; Cornea; Dexamethasone; Endothelium, Vascular; Estradiol; Female; Fibroblast Growth Factor 2; Medroxyprogesterone Acetate; Mifepristone; Neovascularization, Pathologic; Progesterone; Pulmonary Artery; Rabbits; Retinal Vessels; Structure-Activity Relationship | 1994 |
Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
Topics: 17-alpha-Hydroxyprogesterone; Animals; Aorta; Cattle; Cells, Cultured; Dexamethasone; Endothelium, Vascular; Fibroblast Growth Factor 2; Heparin; Hydrocortisone; Hydroxyprogesterones; Medroxyprogesterone Acetate; Neovascularization, Pathologic; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Steroids; Urokinase-Type Plasminogen Activator | 1993 |
Sex steroids regulate the expression of plasminogen activator inhibitor-1 (PAI-1) and its mRNA in uterine endometrial cancer cell line Ishikawa.
Topics: 17-alpha-Hydroxyprogesterone; Adenocarcinoma; DNA, Neoplasm; Endometrial Neoplasms; Estradiol; Female; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Humans; Medroxyprogesterone Acetate; Neoplasm Proteins; Neovascularization, Pathologic; Plasminogen Activator Inhibitor 1; Polymerase Chain Reaction; Progesterone; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1996 |
Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Topics: Breast Neoplasms; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphokines; Medroxyprogesterone Acetate; Megestrol Acetate; Mifepristone; Neoplasm Proteins; Neovascularization, Pathologic; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Progestins; Receptors, Progesterone; Stimulation, Chemical; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
The effect of medroxyprogesterone acetate on angiogenesis in complex endometrial hyperplasia.
Topics: Administration, Oral; Adult; Age Distribution; Aged; Antineoplastic Agents, Hormonal; Case-Control Studies; Endometrial Hyperplasia; Female; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Middle Aged; Neovascularization, Pathologic; Uterus | 1999 |
Inhibition by 9alpha-fluoromedoroxyprogesterone acetate (FMPA) against mammary carcinoma induced by dimethylbenz[a]anthracene in rats and angiogenesis in the rabbit cornea - comparison with medroxyprogesterone acetate (MPA).
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cornea; Dose-Response Relationship, Drug; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Neovascularization, Pathologic; Progesterone; Rabbits; Rats; Rats, Sprague-Dawley; Time Factors | 2000 |
Paradoxical hormone responses of KPL-1 breast cancer cells in vivo: a significant role of angiogenesis in tumor growth.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Division; Cyclohexanes; Endothelial Growth Factors; Female; Humans; Lymphokines; Medroxyprogesterone Acetate; Mitotic Index; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; RNA, Messenger; Sesquiterpenes; Transfection; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by human endometrial cancer.
Topics: Adenocarcinoma; Animals; Cornea; Endometrial Neoplasms; Female; Fibroblast Growth Factor 1; Humans; Medroxyprogesterone Acetate; Neoplasm Transplantation; Neovascularization, Pathologic; Rabbits; Transforming Growth Factor alpha | 1992 |
Angiogenic activity of rat mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibition.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cells, Cultured; Drug Interactions; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Neovascularization, Pathologic; Rats; Rats, Inbred Strains | 1988 |
Inhibition of tumor angiogenesis activity in C3H mouse mammary tumor by medroxyprogesterone acetate.
Topics: Angiogenesis Inducing Agents; Animals; Cattle; Cell Division; Cells, Cultured; Female; Fibroblast Growth Factors; Hydrocortisone; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasm Transplantation; Neovascularization, Pathologic; Pulmonary Artery; Tumor Cells, Cultured | 1989 |
Inhibition of tumor angiogenesis activity by medroxyprogesterone acetate in gynecologic malignant tumors.
Topics: Adenocarcinoma; Angiogenesis Inducing Agents; Carcinoma, Squamous Cell; Cell Division; Cystadenocarcinoma; Female; Fibroblast Growth Factors; Genital Neoplasms, Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neovascularization, Pathologic; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |
Medroxyprogesterone acetate, an anti-cancer and anti-angiogenic steroid, inhibits the plasminogen activator in bovine endothelial cells.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Fibroblast Growth Factors; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Neovascularization, Pathologic; Plasminogen Activators; Plasminogen Inactivators; Time Factors | 1989 |